Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Boston Scientific (BSX) · oqro.io/stocks/BSX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
13 days before an 8-KTraded Aug 25 · filed 1 day later
Since the trade −15.8% · S&P 500 −9.9% · to Nov 20
Bought 54% below the 52-week high, RSI 54, 28% under its 200-day average, 16 points behind the S&P 500 over 3 months
A Boston Scientific director paid $100K out of pocket for Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Shares held went up 17% with this purchase.
Since the trade −10.2% · S&P 500 −7.7% · to Nov 20
Bought 57% below the 52-week high, RSI 58, 36% under its 200-day average, 23 points behind the S&P 500 over 3 months
A Boston Scientific director paid $227K out of pocket for Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Shares held went up 20% with this purchase.
A Boston Scientific director paid $100K out of pocket for Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Shares held went up 14% with this purchase.
The CEO of Boston Scientific paid $9M out of pocket for Boston Scientific shares. 3 other people at Boston Scientific bought some too, in the same month. Shares held went up 13% with this purchase.
A Boston Scientific director paid $203K out of pocket for Boston Scientific shares. 2 other people at Boston Scientific bought some too, in the same month. Shares held went up 16% with this purchase.
A Boston Scientific director paid $100K out of pocket for Boston Scientific shares. 2 other people at Boston Scientific bought some too, in the same month.
10 open-market purchases and 2 open-market sales by insiders of BSX between Jan 5, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 28, 2026. The data provider lists the next release for Feb 2, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Susan E Morano, Director, Aug 25, 2026, about $100K. Bought 27 days after the company's previous earnings release on 2026-07-29Form 4
David C Habiger, Director, Aug 5, 2026, about $100K. Bought 7 days after the company's previous earnings release on 2026-07-29Form 4
David C Habiger, Director, Aug 4, 2026, about $6.8K. Bought 6 days after the company's previous earnings release on 2026-07-29Form 4
David C Habiger, Director, Aug 3, 2026, about $50K. Bought 5 days after the company's previous earnings release on 2026-07-29Form 4
, Chairman, President & CEO, Aug 3, 2026, about $9M. Bought 5 days after the company's previous earnings release on 2026-07-29
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies